Stay updated on Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-21T12:31:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The record for a recruiting Phase 2 study of neoadjuvant pembrolizumab and talimogene laherparepvec for Stage III melanoma is displayed, including eligibility criteria, study design and outcomes, and contact details.
    Difference
    44%
    Check dated 2026-11-07T11:57:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer now identifies the release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T12:41:59.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and says some content may use “Super Intelligence” (SI) instead of “Artificial Intelligence” (AI). It appears above the unchanged 403 error page.
    Difference
    1%
    Check dated 2026-10-24T13:19:07.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer’s site revision identifier advanced from v3.7.1 to v3.7.2, while the page still shows a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T14:09:52.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 page.
    Difference
    0.2%
    Check dated 2026-10-10T14:15:31.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Immunotherapy Combination in Stage III Melanoma Clinical Trial page.